PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23393547-7	2013	Furthermore, delta-tocotrienol induced p27(Kip1) mRNA expression but not its protein degradation.	tocotrienol, delta	13-30	cyclin dependent kinase inhibitor 1B	Homo sapiens	43-47	
23393547-0	2013	Vitamin E delta-tocotrienol induces p27(Kip1)-dependent cell-cycle arrest in pancreatic cancer cells via an E2F-1-dependent mechanism.	tocotrienol, delta	10-27	cyclin dependent kinase inhibitor 1B	Homo sapiens	40-44	
23393547-3	2013	We also showed that delta-tocotrienol-induced growth inhibition occurred concomitantly with G(1) cell-cycle arrest and increased p27(Kip1) nuclear accumulation.	tocotrienol, delta	20-37	cyclin dependent kinase inhibitor 1B	Homo sapiens	133-137	
23393547-5	2013	Furthermore, delta-tocotrienol inactivated RAF-MEK-ERK signaling, a pathway known to suppress p27(Kip1) expression.	tocotrienol, delta	13-30	cyclin dependent kinase inhibitor 1B	Homo sapiens	98-102	
23393547-8	2013	p27(Kip1) gene promoter activity was induced by delta-tocotrienol through the promoter"s E2F-1 binding site, and this activity was attenuated by E2F-1 depletion using E2F-1 small interfering RNA.	tocotrienol, delta	48-65	cyclin dependent kinase inhibitor 1B	Homo sapiens	4-8	
23393547-10	2013	Our findings reveal a new mechanism, dependent on p27(Kip1) induction, by which delta-tocotrienol can inhibit proliferation in PDCA cells, providing a new rationale for p27(Kip1) as a biomarker for delta-tocotrienol efficacy in pancreatic cancer prevention and therapy.	tocotrienol, delta	80-97	cyclin dependent kinase inhibitor 1B	Homo sapiens	54-58	
23393547-10	2013	Our findings reveal a new mechanism, dependent on p27(Kip1) induction, by which delta-tocotrienol can inhibit proliferation in PDCA cells, providing a new rationale for p27(Kip1) as a biomarker for delta-tocotrienol efficacy in pancreatic cancer prevention and therapy.	tocotrienol, delta	80-97	cyclin dependent kinase inhibitor 1B	Homo sapiens	173-177	
23393547-10	2013	Our findings reveal a new mechanism, dependent on p27(Kip1) induction, by which delta-tocotrienol can inhibit proliferation in PDCA cells, providing a new rationale for p27(Kip1) as a biomarker for delta-tocotrienol efficacy in pancreatic cancer prevention and therapy.	tocotrienol, delta	198-215	cyclin dependent kinase inhibitor 1B	Homo sapiens	173-177